Pediatrix Medical Group, Inc.
US ˙ NYSE ˙ US58502B1061

SecurityMD / Pediatrix Medical Group, Inc.
InstitutionCerity Partners LLC
Latest Disclosed Ownership29,714 shares
Latest Disclosed Value $ 635,586
Cerity Partners LLC reports 15.28% increase in ownership of MD / Pediatrix Medical Group, Inc.

On May 15, 2026 - Cerity Partners LLC filed a 13F-HR form disclosing ownership of 29,714 shares of Pediatrix Medical Group, Inc. (US:MD) valued at $635,582 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 25,776 shares of Pediatrix Medical Group, Inc.. This represents a change in shares of 15.28% during the quarter. The current value of the position is $648,954 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 29,714 3,938 15.28 636 15.25 0.0009
2026-02-11 2025-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 25,776 10,302 66.58 551 112.74 0.0008
2025-10-22 2025-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 15,474 15,474 259 0.0004
2018-11-15 2018-09-30 13F MEDNAX COM 58502B106 0 -10,364 -100.00 0 -100.00
2018-08-15 2018-06-30 13F MEDNAX COM 58502B106 10,364 -1,197 -10.35 449 -30.17 0.0332
2018-05-15 2018-03-31 13F MEDNAX COM 58502B106 11,561 -269 -2.27 643 1.74 0.0492
2018-02-14 2017-12-31 13F Mednax COM 58502B106 11,830 -2 -0.02 632 23.92 0.0424
2017-11-13 2017-09-30 13F MEDNAX COM 58502B106 11,832 98 0.84 510 -27.97 0.0361
2017-08-10 2017-06-30 13F Mednax COM 58502B106 11,734 19 0.16 708 -12.92 0.0593
2017-05-02 2017-03-31 13F Mednax COM 58502B106 11,715 11,715 813 0.0679
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.